세계의 대체 암 치료제 시장 - 산업 규모, 점유율, 동향, 기회, 예측 : 치료 유형별, 질환 유형별, 최종 사용자별, 지역별, 경쟁별(2020-2030년)
Alternative Cancer Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Therapy Type, By Disease Type, By End Users, By Region & Competition, 2020-2030F
상품코드:1785196
리서치사:TechSci Research
발행일:2025년 08월
페이지 정보:영문 188 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
세계의 대체 암 치료제 시장 규모는 2024년에 156억 5,000만 달러로 평가되었고, 예측기간 중 CAGR은 9.62%를 나타낼 전망이며, 2030년에는 269억 4,000만 달러에 달할 것으로 예상되고 있습니다.
세계의 대체 암 치료제 시장은 화학요법이나 방사선요법 등의 전통적인 치료와 병행하여 혹은 그 대신에 비전통적인 치료를 요구하는 환자 증가에 따라 급속히 확대하고 있습니다. 이 시장은 한약, 면역 기반 치료, 사이토 카인 요법 및 모노클로 날 항체와 같은 생물학적 제제를 포함하여 신체의 자연적인 방어력을 높이기위한 광범위한 치료를 포함합니다. 이 시장 성장을 뒷받침하는 중요한 요인 중 하나는 기존의 암 치료가 초래하는 잠재적인 부작용에 대한 환자와 의료 제공자의 의식이 높아지고 있다는 것입니다. 그 결과, 환자의 QOL 개선, 부작용 경감, 치료 성적 향상을 기대할 수 있는 보완 대체 요법에 대한 수요가 높아지고 있습니다. 특히 면역요법은 암세포를 표적으로 하여 보다 선택적으로 공격하고 건강한 조직에 대한 해가 적기 때문에 큰 지지를 얻고 있습니다. 2024년 6월 미국 식품의약국(FDA)은 epcoritamab-bysp(엡킨리, Genmab US사)를 2라인 이상의 전신요법 후 재발 또는 난치성 여포성 림프종(FL)의 성인 환자를 대상으로 승인했습니다.
Global Alternative Cancer Therapeutics Market was valued at USD 15.65 billion in 2024 and is expected to reach USD 26.94 billion by 2030 with a CAGR of 9.62% during the forecast period. The global alternative cancer therapeutics market is rapidly expanding as more patients seek non-traditional treatments alongside or in place of conventional therapies like chemotherapy and radiation. This market encompasses a wide range of therapies, including herbal medicines, immune-based treatments, and biologics, such as cytokine therapies and monoclonal antibodies, which aim to enhance the body's natural defenses. One significant driver behind the growth of this market is the increasing awareness among patients and healthcare providers about the potential side effects of conventional cancer treatments. As a result, there is a rising demand for complementary and alternative therapies that promise to improve patient quality of life, reduce side effects, and enhance treatment outcomes. Immunotherapies, in particular, have gained significant traction due to their ability to target and attack cancer cells more selectively, causing less harm to healthy tissues. In June 2024, the U.S. Food and Drug Administration (FDA) approved epcoritamab-bysp (Epkinly, Genmab U.S., Inc.) for adult patients with relapsed or refractory follicular lymphoma (FL) following two or more lines of systemic therapy.
Market Overview
Forecast Period
2026-2030
Market Size 2024
USD 15.65 Billion
Market Size 2030
USD 26.94 Billion
CAGR 2025-2030
9.62%
Fastest Growing Segment
Hormone Therapy
Largest Market
North America
Key Market Drivers
Rising Cancer Incidence
The rising global incidence of cancer is a significant driver of the alternative cancer therapeutics market. For instance, according to the WHO 2025 report, cancer is a leading global cause of death, responsible for nearly 10 million deaths in 2020, or one in six deaths. Common cancers include breast, lung, colon, rectum, and prostate. One-third of cancer deaths are linked to tobacco, obesity, alcohol, poor diet, physical inactivity, and air pollution. As the number of cancer diagnoses continues to increase worldwide, there is a growing demand for diverse treatment options, including alternative therapies. The global cancer burden is influenced by various factors, such as aging populations, lifestyle changes, and environmental exposures. With the traditional cancer treatment methods like chemotherapy and radiation often resulting in harsh side effects, patients are increasingly seeking complementary or alternative approaches to manage their condition and improve their overall well-being. According to the WHO, cancer affects 1 in 5 people, with 1 in 12 women and 1 in 9 men impacted. In 2022, there were 20 million new cancer cases and 9.7 million deaths, while 53.5 million people were alive five years after diagnosis.
As conventional treatments may lead to fatigue, nausea, hair loss, and weakened immune function, cancer patients are looking for therapies that are less invasive, have fewer side effects, and support their overall health. This shift has sparked an increased interest in alternative treatments such as herbal remedies, immunotherapies, and biological treatments, which are believed to offer more targeted and holistic healing solutions. The failure of traditional therapies to cure certain cancer types or the recurrence of the disease after conventional treatment drives patients to explore alternative options that may offer more favorable outcomes.
The rising cancer incidence has also led to greater awareness and acceptance of alternative cancer treatments. Many patients, particularly in developed regions, are more open to exploring non-traditional therapies after experiencing the limitations and side effects of standard treatments. Alongside this, the growing body of research supporting the effectiveness of certain alternative cancer therapies, such as cannabis-based treatments, naturopathy, and immunotherapy, continues to bolster the credibility and demand for these options. As the global cancer epidemic worsens, the alternative cancer therapeutics market is expected to grow, driven by patient demand for more personalized and less toxic treatment regimens to combat cancer.
The growing prevalence of lifestyle disorders like diabetes and obesity, increasing healthcare spending, and the rapidly expanding diagnostic industry are fueling market growth. For example, the American Diabetes Association reports 1.2 million new diabetes diagnoses annually, with 11.6% of Americans affected in 2021. Additionally, the aging population, rising demand for laboratory automation, and greater awareness of preventive healthcare are contributing to market expansion.
Key Market Challenges
Lack of Standardized Regulations
The lack of standardized regulations in the global alternative cancer therapeutics market presents a significant challenge, hindering the widespread acceptance and integration of these treatments into mainstream oncology care. Unlike conventional cancer therapies, which are subject to rigorous regulatory frameworks such as the U.S. Food and Drug Administration (FDA) or the European Medicines Agency (EMA), many alternative treatments-such as herbal remedies, supplements, and other non-traditional therapies-are not consistently regulated. This lack of standardization results in variations in product quality, safety, and efficacy, which can lead to confusion and mistrust among patients and healthcare providers.
Without a universal regulatory framework, the market is flooded with alternative treatments of varying potency, purity, and effectiveness. This inconsistency not only creates challenges for patients seeking reliable treatments but also for healthcare professionals who may find it difficult to recommend or integrate these therapies into their treatment plans. The absence of standardized manufacturing processes means that some alternative cancer treatments may contain harmful substances or contaminants, further raising concerns over patient safety.
The lack of regulation also impacts the clinical development of alternative cancer therapies. Without clear guidelines or standards, it becomes challenging for researchers and companies to conduct large-scale clinical trials to validate the effectiveness of these treatments. As a result, many alternative therapies lack the robust scientific evidence needed to prove their therapeutic value, leaving them on the fringes of cancer care. The patients may turn to unregulated alternative therapies when they seek relief from the side effects of conventional treatments. However, the risk of ineffective or potentially harmful treatments without regulatory oversight increases. A unified regulatory approach, focused on ensuring the safety, efficacy, and quality of alternative cancer therapies, would provide greater confidence to both patients and healthcare providers, promoting the responsible integration of these therapies into cancer treatment protocols.
Key Market Trends
Integration of Conventional and Alternative Therapies
The integration of conventional and alternative therapies is one of the most notable trends in the global alternative cancer therapeutics market, reflecting a shift towards more holistic, personalized, and patient-centered approaches to cancer care. Conventional cancer treatments such as chemotherapy, radiation, and surgery remain the primary modalities for cancer management. However, these treatments often come with significant side effects, such as fatigue, nausea, hair loss, and immune suppression, which can greatly affect a patient's quality of life. As a result, there has been growing interest in integrating alternative therapies, such as acupuncture, herbal remedies, and dietary supplements, into conventional treatment plans to mitigate these side effects and improve overall patient well-being.
Integrative oncology, which combines the best of both conventional and alternative therapies, is gaining acceptance among healthcare providers and patients alike. This approach not only focuses on targeting the cancer itself but also emphasizes addressing the physical, emotional, and psychological needs of cancer patients. By incorporating therapies like yoga, mindfulness meditation, and naturopathy, integrative oncology aims to improve the overall health of the patient and enhance the body's ability to cope with the side effects of aggressive cancer treatments.
Moreover, the growing body of research supporting the benefits of complementary therapies is further promoting this trend. Clinical studies have shown that treatments like acupuncture can reduce pain and nausea associated with chemotherapy, while certain herbal supplements may help enhance the effectiveness of conventional drugs. As a result, cancer care centers and hospitals are increasingly adopting integrative care models, and multidisciplinary teams are collaborating to provide comprehensive treatment plans that combine the latest advancements in both conventional and alternative medicine. This integration not only supports the growing demand for alternative cancer therapies but also opens new avenues for improving patient outcomes and quality of life.
Key Market Players
Innovative Medicine, LLC
Northwest Natural Health Clinic
Immunotherapy Institute
Georgia Cancer Specialists
Holistic Bio Spa
Johnson & Johnson
Celgene Corporation
Astellas Pharma, Inc.
Novartis AG
Merck KGaA
Report Scope:
In this report, the Global Alternative Cancer Therapeutics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Alternative Cancer Therapeutics Market, By Therapy Type:
Hormone Therapies
Acupuncture and Dietary Supplements
Others
Alternative Cancer Therapeutics Market, By Disease Type:
Gastrointestinal
Lung Cancer
Breast Cancer
Colorectal Cancer
Leukemia
Lymphoma
Melanoma
Prostate Cancer
Others
Alternative Cancer Therapeutics Market, By End Users:
Hospitals and Clinics
Cancer and Radiation Therapy Center
Home Care
Others
Alternative Cancer Therapeutics Market, By Region:
North America
United States
Canada
Mexico
Europe
France
United Kingdom
Italy
Germany
Spain
Asia-Pacific
China
India
Japan
Australia
South Korea
South America
Brazil
Argentina
Colombia
Middle East & Africa
South Africa
Saudi Arabia
UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Global Alternative Cancer Therapeutics Market.
Available Customizations:
Global Alternative Cancer Therapeutics Market report with the given market data, TechSci Research, offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
Detailed analysis and profiling of additional market players (up to five).
Table of Contents
1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Alternative Cancer Therapeutics Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Therapy Type (Hormone Therapies, Acupuncture and Dietary Supplements, Others)
5.2.2. By Disease Type (Gastrointestinal, Lung Cancer, Breast Cancer, Colorectal Cancer, Leukemia, Lymphoma, Melanoma, Prostate Cancer, Others)
5.2.3. By End Users (Hospitals and Clinics, Cancer and Radiation Therapy Center, Home Care, Others)
5.2.4. By Region
5.2.5. By Company (2024)
5.3. Product Market Map
5.3.1. By Therapy Type
5.3.2. By Disease Type
5.3.3. By End Users
5.3.4. By Region
6. North America Alternative Cancer Therapeutics Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Therapy Type (Hormone Therapies, Acupuncture and Dietary Supplements, Others)
6.2.2. By Disease Type (Gastrointestinal, Lung Cancer, Breast Cancer, Colorectal Cancer, Leukemia, Lymphoma, Melanoma, Prostate Cancer, Others)
6.2.3. By End Users (Hospitals and Clinics, cancer and Radiation Therapy Center, Home Care, Others)
6.2.4. By Country
6.3. North America: Country Analysis
6.3.1. United States Alternative Cancer Therapeutics Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Therapy Type
6.3.1.2.2. By Disease Type
6.3.1.2.3. By End User
6.3.2. Canada Alternative Cancer Therapeutics Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Therapy Type
6.3.2.2.2. By Disease Type
6.3.2.2.3. By End User
6.3.3. Mexico Alternative Cancer Therapeutics Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Therapy Type
6.3.3.2.2. By Disease Type
6.3.3.2.3. By End User
7. Europe Alternative Cancer Therapeutics Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Therapy Type (Hormone Therapies, Acupuncture and Dietary Supplements, Others)
7.2.2. By Disease Type (Gastrointestinal, Lung Cancer, Breast Cancer, Colorectal Cancer, Leukemia, Lymphoma, Melanoma, Prostate Cancer, Others)
7.2.3. By End Users (Hospitals and Clinics, cancer and Radiation Therapy Center, Home Care, Others)
7.2.4. By Country
7.3. Europe: Country Analysis
7.3.1. France Alternative Cancer Therapeutics Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Therapy Type
7.3.1.2.2. By Disease Type
7.3.1.2.3. By End User
7.3.2. Germany Alternative Cancer Therapeutics Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Therapy Type
7.3.2.2.2. By Disease Type
7.3.2.2.3. By End User
7.3.3. United Kingdom Alternative Cancer Therapeutics Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Therapy Type
7.3.3.2.2. By Disease Type
7.3.3.2.3. By End User
7.3.4. Italy Alternative Cancer Therapeutics Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Therapy Type
7.3.4.2.2. By Disease Type
7.3.4.2.3. By End User
7.3.5. Spain Alternative Cancer Therapeutics Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Therapy Type
7.3.5.2.2. By Disease Type
7.3.5.2.3. By End User
8. Asia-Pacific Alternative Cancer Therapeutics Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Therapy Type (Hormone Therapies, Acupuncture and Dietary Supplements, Others)
8.2.2. By Disease Type (Gastrointestinal, Lung Cancer, Breast Cancer, Colorectal Cancer, Leukemia, Lymphoma, Melanoma, Prostate Cancer, Others)
8.2.3. By End Users (Hospitals and Clinics, cancer and Radiation Therapy Center, Home Care, Others)
8.2.4. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Alternative Cancer Therapeutics Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Therapy Type
8.3.1.2.2. By Disease Type
8.3.1.2.3. By End User
8.3.2. India Alternative Cancer Therapeutics Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Therapy Type
8.3.2.2.2. By Disease Type
8.3.2.2.3. By End User
8.3.3. Japan Alternative Cancer Therapeutics Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Therapy Type
8.3.3.2.2. By Disease Type
8.3.3.2.3. By End User
8.3.4. South Korea Alternative Cancer Therapeutics Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Therapy Type
8.3.4.2.2. By Disease Type
8.3.4.2.3. By End User
8.3.5. Australia Alternative Cancer Therapeutics Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Therapy Type
8.3.5.2.2. By Disease Type
8.3.5.2.3. By End User
9. South America Alternative Cancer Therapeutics Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Therapy Type (Hormone Therapies, Acupuncture and Dietary Supplements, Others)
9.2.2. By Disease Type (Gastrointestinal, Lung Cancer, Breast Cancer, Colorectal Cancer, Leukemia, Lymphoma, Melanoma, Prostate Cancer, Others)
9.2.3. By End Users (Hospitals and Clinics, cancer and Radiation Therapy Center, Home Care, Others)
9.2.4. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Alternative Cancer Therapeutics Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Therapy Type
9.3.1.2.2. By Disease Type
9.3.1.2.3. By End User
9.3.2. Argentina Alternative Cancer Therapeutics Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Therapy Type
9.3.2.2.2. By Disease Type
9.3.2.2.3. By End User
9.3.3. Colombia Alternative Cancer Therapeutics Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Therapy Type
9.3.3.2.2. By Disease Type
9.3.3.2.3. By End User
10. Middle East and Africa Alternative Cancer Therapeutics Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Therapy Type (Hormone Therapies, Acupuncture and Dietary Supplements, Others)
10.2.2. By Disease Type (Gastrointestinal, Lung Cancer, Breast Cancer, Colorectal Cancer, Leukemia, Lymphoma, Melanoma, Prostate Cancer, Others)
10.2.3. By End Users (Hospitals and Clinics, cancer and Radiation Therapy Center, Home Care, Others)
10.2.4. By Country
10.3. MEA: Country Analysis
10.3.1. South Africa Alternative Cancer Therapeutics Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Therapy Type
10.3.1.2.2. By Disease Type
10.3.1.2.3. By End User
10.3.2. Saudi Arabia Alternative Cancer Therapeutics Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Therapy Type
10.3.2.2.2. By Disease Type
10.3.2.2.3. By End User
10.3.3. UAE Alternative Cancer Therapeutics Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Therapy Type
10.3.3.2.2. By Disease Type
10.3.3.2.3. By End User
11. Market Dynamics
11.1. Drivers
11.1.1 Growing Prevalence of Cancer
11.1.2 Growing Healthcare Expenditure
11.2. Challenges
11.2.1 Lack of Awareness about New Therapies
11.2.2 High Cost of Treatment
12. Market Trends & Developments
12.1. Recent Development
12.2. Mergers & Acquisitions
12.3. Product Launches
13. Global Alternative Cancer Therapeutics Market: SWOT Analysis
